Your browser doesn't support javascript.
loading
Istradefylline protects from cisplatin-induced nephrotoxicity and peripheral neuropathy while preserving cisplatin antitumor effects.
Dewaeles, Edmone; Carvalho, Kévin; Fellah, Sandy; Sim, Jaewon; Boukrout, Nihad; Caillierez, Raphaelle; Ramakrishnan, Hariharan; Van der Hauwaert, Cynthia; Vijaya Shankara, Jhenkruthi; Martin, Nathalie; Massri, Noura; Launay, Agathe; Folger, Joseph K; de Schutter, Clémentine; Larrue, Romain; Loison, Ingrid; Goujon, Marine; Jung, Matthieu; Le Gras, Stéphanie; Gomez-Murcia, Victoria; Faivre, Emilie; Lemaire, Julie; Garat, Anne; Beauval, Nicolas; Maboudou, Patrice; Gnemmi, Viviane; Gibier, Jean-Baptiste; Buée, Luc; Abbadie, Corinne; Glowacki, Francois; Pottier, Nicolas; Perrais, Michael; Cunha, Rodrigo A; Annicotte, Jean-Sébastien; Laumet, Geoffroy; Blum, David; Cauffiez, Christelle.
Afiliação
  • Dewaeles E; University of Lille, INSERM, CNRS, CHU Lille, UMR9020-U1277, CANTHER, Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, France.
  • Carvalho K; University of Lille, INSERM, CHU Lille, UMR-S1172 LilNCog, Lille Neuroscience and Cognition, Lille, France.
  • Fellah S; University of Lille, INSERM, CHU Lille, UMR-S1172 LilNCog, Lille Neuroscience and Cognition, Lille, France.
  • Sim J; Alzheimer and Tauopathies, LabEx DISTALZ, Lille, France.
  • Boukrout N; University of Lille, INSERM, CNRS, CHU Lille, UMR9020-U1277, CANTHER, Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, France.
  • Caillierez R; Department of Physiology, Michigan State University, East Lansing, Michigan, USA.
  • Ramakrishnan H; Cell and Molecular Biology Graduate program, Michigan State University, East Lansing, Michigan, USA.
  • Van der Hauwaert C; University of Lille, INSERM, CNRS, CHU Lille, UMR9020-U1277, CANTHER, Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, France.
  • Vijaya Shankara J; University of Lille, INSERM, CHU Lille, UMR-S1172 LilNCog, Lille Neuroscience and Cognition, Lille, France.
  • Martin N; Alzheimer and Tauopathies, LabEx DISTALZ, Lille, France.
  • Massri N; Department of Physiology, Michigan State University, East Lansing, Michigan, USA.
  • Launay A; University of Lille, INSERM, CNRS, CHU Lille, UMR9020-U1277, CANTHER, Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, France.
  • Folger JK; CHU Lille, Département de la Recherche en Santé, Lille, France.
  • de Schutter C; University of Lille, INSERM, CHU Lille, UMR-S1172 LilNCog, Lille Neuroscience and Cognition, Lille, France.
  • Larrue R; Alzheimer and Tauopathies, LabEx DISTALZ, Lille, France.
  • Loison I; University of Lille, INSERM, CNRS, CHU Lille, UMR9020-U1277, CANTHER, Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, France.
  • Goujon M; Department of Physiology, Michigan State University, East Lansing, Michigan, USA.
  • Jung M; Cell and Molecular Biology Graduate program, Michigan State University, East Lansing, Michigan, USA.
  • Le Gras S; University of Lille, INSERM, CHU Lille, UMR-S1172 LilNCog, Lille Neuroscience and Cognition, Lille, France.
  • Gomez-Murcia V; Alzheimer and Tauopathies, LabEx DISTALZ, Lille, France.
  • Faivre E; Department of Physiology, Michigan State University, East Lansing, Michigan, USA.
  • Lemaire J; University of Lille, INSERM, CNRS, CHU Lille, UMR9020-U1277, CANTHER, Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, France.
  • Garat A; University of Lille, INSERM, CNRS, CHU Lille, UMR9020-U1277, CANTHER, Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, France.
  • Beauval N; CHU Lille, Service de Toxicologie et Génopathies, Lille, France.
  • Maboudou P; University of Lille, INSERM, CNRS, CHU Lille, UMR9020-U1277, CANTHER, Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, France.
  • Gnemmi V; University of Lille, INSERM, CNRS, CHU Lille, UMR9020-U1277, CANTHER, Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, France.
  • Gibier JB; University of Strasbourg, CNRS UMR 7104, INSERM U1258 - GenomEast Platform - IGBMC - Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, France.
  • Buée L; University of Strasbourg, CNRS UMR 7104, INSERM U1258 - GenomEast Platform - IGBMC - Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, France.
  • Abbadie C; University of Lille, INSERM, CHU Lille, UMR-S1172 LilNCog, Lille Neuroscience and Cognition, Lille, France.
  • Glowacki F; Alzheimer and Tauopathies, LabEx DISTALZ, Lille, France.
  • Pottier N; University of Lille, INSERM, CHU Lille, UMR-S1172 LilNCog, Lille Neuroscience and Cognition, Lille, France.
  • Perrais M; Alzheimer and Tauopathies, LabEx DISTALZ, Lille, France.
  • Cunha RA; University of Lille, INSERM, CNRS, CHU Lille, UMR9020-U1277, CANTHER, Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, France.
  • Annicotte JS; CHU Lille, Service de Toxicologie et Génopathies, Lille, France.
  • Laumet G; University of Lille, CHU Lille, Institut Pasteur de Lille, ULR 4483, IMPact de l'Environnement Chimique sur la Santé Humaine (IMPECS), Lille, France.
  • Blum D; CHU Lille, Service de Toxicologie et Génopathies, Lille, France.
  • Cauffiez C; University of Lille, CHU Lille, Institut Pasteur de Lille, ULR 4483, IMPact de l'Environnement Chimique sur la Santé Humaine (IMPECS), Lille, France.
J Clin Invest ; 132(22)2022 11 15.
Article em En | MEDLINE | ID: mdl-36377661

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neuralgia / Antineoplásicos Limite: Animals Idioma: En Revista: J Clin Invest Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neuralgia / Antineoplásicos Limite: Animals Idioma: En Revista: J Clin Invest Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França País de publicação: Estados Unidos